1. Albrightson CR, Bugelski PJ, Berkhout TA, Jackson B, Kerns WD, Organ AJ, Badger AM (1995): Separation of immunomodulatory and cholesterol lowering activities of heterocyclic azaspiranes. J Pharm Exp Ther 272: 689–698
2. Albrightson-Winslow CR, Brickson B, King A, Olivera D, Short B, Saunders C, Badger AM (1990): Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis. J Pharm Exp Ther 255(1): 382–387
3. Badger AM, Albrightson-Winslow CR, Kupiec-Weglinski JW (1991a): SK&F 105685: A novel immunosuppressive compound with efficacy in animal models of autoimmunity and transplantation. Trans Proc 23(1): 194–195
4. Badger AM, DiMartino MJ, Schmitt TC, Swift BA, Mirabelli CK (1987): Suppressor cell induction by the anticancer drug Spirogermanium. Int J Immunopharmac 9(5): 621–630
5. Badger AM, DiMartino MJ, Talmadge JE, Picker DH, Schwartz DA, Dorman JW, Mirabelli CK, Hanna N (1989): Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes. Int J Immunopharmac 11(7): 839–846